Pneumoconiosis cost-effectiveness of therapy: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
No edit summary |
||
Line 2: | Line 2: | ||
{{Pneumoconiosis}} | {{Pneumoconiosis}} | ||
{{CMG}}; {{AE}} [[User:Dushka|Dushka Riaz, MD]] | {{CMG}}; {{AE}} [[User:Dushka|Dushka Riaz, MD]] | ||
==Overview== | |||
==Cost-effectiveness of Therapy== | |||
==References== | ==References== | ||
Revision as of 19:35, 26 April 2021
Pneumoconiosis Microchapters |
Diagnosis |
---|
Treatment |
Case Studies |
Pneumoconiosis cost-effectiveness of therapy On the Web |
American Roentgen Ray Society Images of Pneumoconiosis cost-effectiveness of therapy |
Risk calculators and risk factors for Pneumoconiosis cost-effectiveness of therapy |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Dushka Riaz, MD